There were two studies that showed higher basal FSH levels (Oktay et al., 2006; Quintero et al., 2010), while the other two reported no difference in patients with breast cancer (Lutchman Singh et al., 2007; Gunnala et al., 2019). Here, BRD2 is linked to breast carcinoma.